| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60da379fb33c192ef77f86a60c5ac029 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 |
| filingDate |
1993-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1994-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf075455b42baf5c9ddda1741ad05064 |
| publicationDate |
1994-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5328930-A |
| titleOfInvention |
Treatment of microsporidial and acanthamoeba keratoconjunctivitis with topical fumagillin |
| abstract |
Methods for the treatment of Microsporidia keratoconjunctivitis and Acanthamoeba keratitis are disclosed that include the topical administration of an effective amount of fumagillin or a derivative or pharmaceutically acceptable salt thereof, in a pharmaceutically acceptable carrier or diluent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6207704-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5900431-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6566541-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9067913-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8772333-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6521764-B1 |
| priorityDate |
1993-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |